The AAT multiple activities have suggested a potential therapeutic use of AAT for the treatment of several inflammatory and autoimmune diseases beyond COPD, as well as viral diseases including HIV-1 infection, whereby AAT infusion can decrease HIV viral load (Forssmann et al., 2010; Lewis, 2012; Wanner et al., 2012). Here, SERPINA1 is linked to HIV-1 infection.